Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Glucose metabolism |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| A (strongly recommended) |
| Level of Evidence |
| well-established clinical and NM recommendations recommendations |
| Effective Dose |
| 19.0 µSv/MBq |
| Bibliographic Reference |
|
Cavo, M., Terpos, E., Nanni, C. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensu...
read more
Cavo, M., Terpos, E., Nanni, C. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017; https://doi.org/10.1016/S1470-2045(17)30189-4
Hillengass, J., Usmani, S., Rajkumar, S. V., Durie, B. G. M., Mateos, M.-V., Lonial, S. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019; https://doi.org/10.1016/S1470-2045(19)30309-2 Kumar, S., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., ... & Avet-Loiseau, H. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016; https://doi.org/10.1016/S1470-2045(16)30206-6 read less |
| Guide to Nuclear Medicine |
| Read the corresponding chapter |